Literature DB >> 28053030

Tau Isoforms Imbalance Impairs the Axonal Transport of the Amyloid Precursor Protein in Human Neurons.

Valentina Lacovich1,2, Sonia L Espindola3, Matías Alloatti1, Victorio Pozo Devoto1, Lucas E Cromberg1, Mária E Čarná2, Giancarlo Forte2, Jean-Marc Gallo4, Luciana Bruno5, Gorazd B Stokin2, M Elena Avale6, Tomás L Falzone7,8.   

Abstract

Tau, as a microtubule (MT)-associated protein, participates in key neuronal functions such as the regulation of MT dynamics, axonal transport, and neurite outgrowth. Alternative splicing of exon 10 in the tau primary transcript gives rise to protein isoforms with three (3R) or four (4R) MT binding repeats. Although tau isoforms are balanced in the normal adult human brain, imbalances in 3R:4R ratio have been tightly associated with the pathogenesis of several neurodegenerative disorders, yet the underlying molecular mechanisms remain elusive. Several studies exploiting tau overexpression and/or mutations suggested that perturbations in tau metabolism impair axonal transport. Nevertheless, no physiological model has yet demonstrated the consequences of altering the endogenous relative content of tau isoforms over axonal transport regulation. Here, we addressed this issue using a trans-splicing strategy that allows modulating tau exon 10 inclusion/exclusion in differentiated human-derived neurons. Upon changes in 3R:4R tau relative content, neurons showed no morphological changes, but live imaging studies revealed that the dynamics of the amyloid precursor protein (APP) were significantly impaired. Single trajectory analyses of the moving vesicles showed that predominance of 3R tau favored the anterograde movement of APP vesicles, increasing anterograde run lengths and reducing retrograde runs and segmental velocities. Conversely, the imbalance toward the 4R isoform promoted a retrograde bias by a significant reduction of anterograde velocities. These findings suggest that changes in 3R:4R tau ratio has an impact on the regulation of axonal transport and specifically in APP dynamics, which might link tau isoform imbalances with APP abnormal metabolism in neurodegenerative processes. SIGNIFICANCE STATEMENT: The tau protein has a relevant role in the transport of cargos throughout neurons. Dysfunction in tau metabolism underlies several neurological disorders leading to dementia. In the adult human brain, two tau isoforms are found in equal amounts, whereas changes in such equilibrium have been associated with neurodegenerative diseases. We investigated the role of tau in human neurons in culture and found that perturbations in the endogenous balance of tau isoforms were sufficient to impair the transport of the Alzheimer's disease-related amyloid precursor protein (APP), although neuronal morphology was normal. Our results provide evidence of a direct relationship between tau isoform imbalance and defects in axonal transport, which induce an abnormal APP metabolism with important implications in neurodegeneration.
Copyright © 2017 the authors 0270-6474/17/370059-12$15.00/0.

Entities:  

Keywords:  APP; Alzheimer's; axonal transport; splicing; tau; tauopathies

Mesh:

Substances:

Year:  2017        PMID: 28053030      PMCID: PMC6705673          DOI: 10.1523/JNEUROSCI.2305-16.2016

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  34 in total

1.  Live-Cell Imaging Reveals Tau Isoforms Imbalance Disrupts Traffic of APP Vesicles in Human Neurons.

Authors:  Christy Oi Ying Hung
Journal:  J Neurosci       Date:  2017-02-22       Impact factor: 6.167

Review 2.  Alternative splicing as a regulator of development and tissue identity.

Authors:  Francisco E Baralle; Jimena Giudice
Journal:  Nat Rev Mol Cell Biol       Date:  2017-05-10       Impact factor: 94.444

3.  The Giant Axon of the Squid: A Simple System for Axonal Transport Studies.

Authors:  Joseph A DeGiorgis; Marcus Jang; Elaine L Bearer
Journal:  Methods Mol Biol       Date:  2022

4.  DYRK1A regulates the bidirectional axonal transport of APP in human-derived neurons.

Authors:  Iván Fernandez Bessone; Jordi Navarro; Emanuel Martinez; Karina Karmirian; Mariana Holubiec; Matias Alloatti; Livia Goto-Silva; Cayetana Arnaiz Yepez; Daniel Martins-de-Souza; Juliana Minardi Nascimento; Luciana Bruno; Trinidad M Saez; Stevens K Rehen; Tomás L Falzone
Journal:  J Neurosci       Date:  2022-07-08       Impact factor: 6.709

Review 5.  Amyloid-β and tau complexity - towards improved biomarkers and targeted therapies.

Authors:  Juan Carlos Polanco; Chuanzhou Li; Liviu-Gabriel Bodea; Ramon Martinez-Marmol; Frederic A Meunier; Jürgen Götz
Journal:  Nat Rev Neurol       Date:  2017-12-15       Impact factor: 42.937

Review 6.  Axonal transport and neurological disease.

Authors:  James N Sleigh; Alexander M Rossor; Alexander D Fellows; Andrew P Tosolini; Giampietro Schiavo
Journal:  Nat Rev Neurol       Date:  2019-09-26       Impact factor: 42.937

7.  Modeling tau pathology in human stem cell derived neurons.

Authors:  Selina Wray
Journal:  Brain Pathol       Date:  2017-07       Impact factor: 6.508

8.  Efficient Derivation of Excitatory and Inhibitory Neurons from Human Pluripotent Stem Cells Stably Expressing Direct Reprogramming Factors.

Authors:  Saera Song; Archana Ashok; Damian Williams; Maria Kaufman; Karen Duff; Andrew Sproul
Journal:  Curr Protoc       Date:  2021-06

9.  Selective targeting of 3 repeat Tau with brain penetrating single chain antibodies for the treatment of neurodegenerative disorders.

Authors:  Brian Spencer; Sven Brüschweiler; Marco Sealey-Cardona; Edward Rockenstein; Anthony Adame; Jazmin Florio; Michael Mante; Ivy Trinh; Robert A Rissman; Robert Konrat; Eliezer Masliah
Journal:  Acta Neuropathol       Date:  2018-06-14       Impact factor: 17.088

Review 10.  Autophagic Pathways to Clear the Tau Aggregates in Alzheimer's Disease.

Authors:  Nalini Vijay Gorantla; Subashchandrabose Chinnathambi
Journal:  Cell Mol Neurobiol       Date:  2020-06-11       Impact factor: 5.046

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.